[Analysis of the N-acetyltransferase 2 gene polymorphism in the patients with chronic obstructive pulmonary disease and in populations of the Volga-Ural region]

Genetika. 2003 Jun;39(6):855-7.
[Article in Russian]

Abstract

Restriction fragment-length polymorphism of the gene coding for N-acetyltransferase 2 (NAT2) was typed in populations of the Volga-Ural region (Bashkirs, Tatars, Chuvashes, Udmurts, and Russians) as well as in patients with chronic obstructive pulmonary disease (COPD) and in healthy individuals. Rapid and slow acetylator phenotypes were determined based on the presence or absence of the KpnI, TaqI, and BamHI restriction endonuclease recognition sites. The proportion of slow acetylators in the populations examined varied from 40.00% in Bashkirs to 64.15% in Chuvashes with statistically significant difference between these two ethnic groups (chi 2 = 5.7; p = 0.02). Overall, in the Volga-Ural populations slow acetylators represented 56.25% of the subjects examined. This value was similar to those presented in other studies of Caucasoid populations. In the COPD patients a statistically significant decrease of the slow acetylator frequency to 48.28% compared to healthy individuals (62.18%) was observed (chi 2 = 4.60; p = 0.036). The data obtained suggest a possible association between the drug resistance in the COPD patients with the rapid acetylator phenotype, which can lead to the development of the chronic form of the disease.

MeSH terms

  • Arylamine N-Acetyltransferase / genetics*
  • Bashkiria
  • Deoxyribonuclease BamHI / genetics
  • Deoxyribonucleases, Type II Site-Specific / genetics
  • Genetics, Population*
  • Humans
  • Polymorphism, Genetic
  • Polymorphism, Restriction Fragment Length
  • Pulmonary Disease, Chronic Obstructive / genetics*
  • Reference Values
  • White People / genetics

Substances

  • Arylamine N-Acetyltransferase
  • NAT2 protein, human
  • Deoxyribonuclease BamHI
  • Deoxyribonucleases, Type II Site-Specific
  • GGTACC-specific type II deoxyribonucleases
  • TCGA-specific type II deoxyribonucleases